Department of Cardiac Surgery, Kerckhoff-Heart Center Bad Nauheim, Justus-Liebig University Giessen, Benekestraße 2-8, 61231, Bad Nauheim, Germany.
Institute for Pharmacology and Preventive Medicine, Cloppenburg, Germany.
BMC Cardiovasc Disord. 2021 Jun 26;21(1):314. doi: 10.1186/s12872-021-02121-3.
Mitral valve (MV) surgery has traditionally been performed by conventional sternotomy (CS), but more recently minimally invasive surgery (MIS) has become another treatment option. The aim of this study is to compare short- and long-term results of MV surgery after CS and MIS.
This study was a retrospective propensity-matched analysis of MV operations between January 2005 and December 2015.
Among 1357 patients, 496 underwent CS and 861 MIS. Matching resulted in 422 patients per group. The procedure time was longer with MIS than CS (192 vs. 185 min; p = 0.002) as was cardiopulmonary bypass time (133 vs. 101 min; p < 0.001) and X-clamp time (80 vs. 71 min; p < 0.001). 'Short-term' successful valve repair was higher with MIS (96.0% vs. 76.0%, p < 0.001). Length of hospital stay was shorter in MIS than CS patients (10 vs. 11 days; p = 0.001). There was no difference in the overall 30-day mortality rate. Cardiovascular death was lower after MIS (1.2%) compared with CS (3.8%; OR 0.30; 95%CI 0.11-0.84). The difference did not remain significant after adjustment for procedural differences (aOR 0.40; 95%CI 0.13-1.25). Pacemaker was required less often after MIS (3.3%) than CS (11.2%; aOR 0.31; 95%CI 0.16-0.61), and acute renal failure was less common (2.1% vs. 11.9%; aOR 0.22; 95%CI 0.10-0.48). There were no significant differences with respect to rates of stroke, myocardial infarction or repeat MV surgery. The 7-year survival rate was significantly better after MIS (88.5%) than CS (74.8%; aHR 0.44, 95%CI 0.31-0.64).
This study demonstrates that good results for MV surgery can be obtained with MIS, achieving a high MV repair rate, low peri-procedural morbidity and mortality, and improved long-term survival.
二尖瓣(MV)手术传统上通过常规胸骨切开术(CS)进行,但最近微创外科(MIS)已成为另一种治疗选择。本研究旨在比较 CS 和 MIS 后 MV 手术的短期和长期结果。
这是一项回顾性倾向匹配分析,研究对象为 2005 年 1 月至 2015 年 12 月期间接受 MV 手术的患者。
在 1357 名患者中,496 名接受 CS,861 名接受 MIS。匹配后每组有 422 名患者。MIS 的手术时间长于 CS(192 分钟 vs. 185 分钟;p=0.002),体外循环时间(133 分钟 vs. 101 分钟;p<0.001)和 X 夹钳时间(80 分钟 vs. 71 分钟;p<0.001)。MIS 的“短期”成功瓣膜修复率更高(96.0% vs. 76.0%,p<0.001)。MIS 患者的住院时间短于 CS 患者(10 天 vs. 11 天;p=0.001)。30 天总死亡率无差异。MIS 后心血管死亡较低(1.2% vs. CS 3.8%;OR 0.30;95%CI 0.11-0.84)。在调整操作差异后,差异不再显著(aOR 0.40;95%CI 0.13-1.25)。MIS 后需要起搏器的患者较少(3.3% vs. CS 11.2%;aOR 0.31;95%CI 0.16-0.61),急性肾衰竭较少见(2.1% vs. CS 11.9%;aOR 0.22;95%CI 0.10-0.48)。在中风、心肌梗死或再次 MV 手术方面无显著差异。MIS 后 7 年生存率显著高于 CS(88.5% vs. CS 74.8%;aHR 0.44,95%CI 0.31-0.64)。
本研究表明,MIS 可获得良好的 MV 手术结果,实现高 MV 修复率、低围手术期发病率和死亡率以及改善长期生存率。